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Influence of Incentive Design and Organizational Characteristics
on Wellness Participation and Health Outcomes
Jessica Grossmeier, PhD, MPH, David J. Mangen, PhD, David R. Anderson, PhD, Stefan B. Gingerich, MS,
Rebecca J. Mitchell, MPH, Mary T. Imboden, PhD, Gordon D. Kaplan, PhD, Gregg M. Gascon, PhD,
Seth A. Serxner, PhD, MPH, and Tony Bodak, MBA

Objective: To explore how changing incentive designs influence wellness
participation and health outcomes. Methods: Aggregated retrospective data
were evaluated using cluster analysis to group 174 companies into incentive
design types. Numerous statistical models assessed between-group differences in wellness participation, earning incentives, and over-time differences
in health outcomes. Results: Four incentive design groups based on requirements for earning incentives were identified. The groups varied in support for
and participation in wellness initiatives within each company. All four design
types were associated with improved low density lipoprotein (LDL)
(P < 0.01), three with improved blood pressure (P < 0.001), and two with
improved fasting glucose (P < 0.03). No incentive plan types were associated with improved body mass index (BMI), but designs predominantly
focused on health outcomes (eg, Outcomes-Focused) exhibited a significant
increase over time in BMI risk. Conclusion: Incentive design and organizational characteristics impact population-level participation and health
outcomes.
Keywords: blood pressure, body mass index, cholesterol, glucose, health
promotion, humans, incentives, motivation, occupational health, workplace

E

mployers invest in workplace health and well-being (HWB)
initiatives to improve employee health, reduce health care
costs, and improve productivity,1 as well as to promote their brand
as an ‘‘employer of choice’’ to attract the best employees.2 One of
the biggest challenges companies face in achieving such outcomes
is engaging employees in components of these HWB initiatives.3,4
Because a lack of incentives has been posited as a reason employees
do not participate in programs5 and the use of incentives has been
linked to participation in HWB components,6– 8 many companies
have responded by offering financial incentives to encourage
employee participation and engagement in their health.
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A representative survey of US companies found that most
(53%) offered incentives, with larger employers being most likely
to offer them (78%).4 Research has shown an association between
the use of financial incentives and participation in health assessment (HA) activities (eg, health risk assessment surveys, biometric
health screenings), participation in health behavior interventions,6 – 8 and short-term improvements in health behaviors, such
as increased physical activity and reduced tobacco use.9 – 14 These
changes were typically made in association with participation in a
health behavior change program,15 – 18 and all of these studies
focused on individual-level participation in HWB initiatives,
behavior change, and health outcomes. There is a dearth of research
examining the independent effect of incentives on populationlevel results.
Since companies continue to provide financial incentives
in their HWB initiatives, it is important to increase our understanding of what types of incentive designs are effective19 in
increasing population-level participation rates and improving
population-level health behaviors and clinical outcomes. A population focus is important because, even if a strategy is effective
in producing substantial health improvements for some individuals, low participation rates could result in little value to the
organization,20 threatening stakeholder support, and funding for
HWB initiatives.
Several factors complicate our understanding about the
effectiveness of incentive strategies. Numerous studies indicate
that incentive design matters,6,8,19 as well as the amount of the
incentive.12,20 – 22 Organizational, environmental, and programmatic supports associated with incentives have also been shown
to influence effectiveness.6,21 – 24 Examples of organizational support include creating a health-supportive workplace culture, having
comprehensive programs and communication strategies in place,
and involving union leadership in discussions about incentives.
Characteristics of the target population also plays a role in incentive
effectiveness.23 – 25 For example, age and sex of the employee
population influence and sometimes interact with incentives to
influence program participation and outcomes.25 Companies may
also change their incentive approaches over time, making realworld research even more challenging. For example, a 2018 study
of large employers reported that incentive design changes often
involve requirements for employee program enrollment or completion, progress towards a goal, and achievement of health outcomes.26
The current study addressed three research questions. The
first question was how companies changed their financial incentive
strategies over time as indicated by the amount of incentive offered
and what was rewarded. The second question was how incentive
design and changes influenced population-level participation in HA
and health behavior change interventions. The third question was
how changes in incentive design influenced population-level health
outcomes, specifically blood pressure, BMI, glucose, and low
density lipoprotein (LDL). For each research question, the influences of organizational characteristics and supports for HWB
initiatives were also explored.

DATA AND METHODS
Sample
The Health Enhancement Research Organization (HERO)
invited member organizations that provide HWB and incentive
management services to companies to voluntarily share de-identified aggregate retrospective client data in support of the study. Three
national suppliers of HWB incentive administration services (study
data suppliers) volunteered to participate. No inducements were
offered to the data suppliers other than to invite them to collaborate
as members of the study team.
Study data suppliers provided data on the evolution over time
of the incentive plans in their client companies, elements of their
HWB initiatives, level of program participation, and health outcomes. Information was also provided about employee demographics, organizational characteristics, and the organizational
and programmatic supports in place during the initial incentive
implementation period. All data represented company-level aggregate statistics rather than individual employee data. Specifically,
data suppliers were asked to provide data based on the following
criteria:
1. Client organizations (ie, the clients of the data suppliers) permitted the use of de-identified, population-level data for
research purposes.
2. Aggregate biometric health screening data of all individuals
included for at least two points in time.
3. At least 1 year separated the baseline and a follow-up screening
measurement period for all individuals.
4. Baseline implementation period occurred before substantial
health interventions were offered.
5. The two study data points were separated by as many years
as possible.
6. Calendar years represented in the data were specified.
7. Information was available on the organizational and programmatic supports in place when the first measurement year
was implemented.
8. Data were provided for continuously enrolled employees (no
spouses or dependents) who were all eligible for the same
incentive plan.
Data suppliers provided data for 174 unique employers. Data
were integrated by HERO and de-identified so that the analysis was
blinded to which records were provided by each data supplier.
Additional data pertaining to the structure of the incentive program,
employee participation in program activities, incentives earned, and
health outcomes were provided both for the beginning (Time 1 or
T1) and end (Time 2 or T2) of the study period. Each company
included in the file had both a T1 and a T2 measurement, but T1 and
T2 were not necessarily the same calendar year for different
companies. Study years for companies ranged from 2008 through
2017.
Data on the size of the employer were available for 93 of the
companies, with a minimum total number of employees of 95 and a
maximum of 24,940. All companies provided data on the number of
employees eligible for an incentive, with a mean of 1127 employees. Study eligibility, a measure that captures the number of people
for whom screening data were available at the two time points,
ranged from five to 11,514 employees, with a mean of 498. The
sharp decrease from those eligible for the incentive to those
included in the study can be attributed to employee turnover
associated with elapsed time covered by the study, and to lack
of biometric data for both periods of measurement. The lack of
biometric data may have been due to initial biometric screening
participants deciding not to participate in a repeat biometric
screening assessment.

Of the study-eligible organizations, 39.1% were service
industry companies, with manufacturing companies making up
another 37.4% of the sample. Companies included in the sample
varied considerably in employee sex and age distributions, with the
company-level mean being 56.1% men and 44.8 years of age.
Slightly less than half of all employees were study-eligible. The
elapsed time covered by the study ranged from 1 year to 7 years,
with a mean of 3.0 years.

Measures
Sets of items that addressed conceptually similar metrics
were combined to create scale scores to support analysis. These
measures, and the procedural rules used to create the scale scores,
are as follows:

HWB Support Index
This measure is a composite scale created from seven items
addressing the degree to which the employing organization provided
a supportive environment for HWB during the baseline (T1) incentive implementation period. It was not measured longitudinally
since it was assumed that these supports did not change substantially
during the study period. Data suppliers relied on documentation
about each of their clients to provide data on the seven items. Four
items addressed the effectiveness of program implementation,
including strategic planning, organizational support, participation
strategies (eg, communications about programs), and evaluation
activities. Companies that were rated as either effective or very
effective received one point on the index for each of these four
aspects of their program implementation. Three items addressed
core functionality of the HWB initiative: inclusion of follow-up and
referrals for employees with abnormal biometric values, offering
health behavior change programs to all individuals regardless of
health status, and providing individually-targeted lifestyle behavior
change programs based on elevated risk. Additional information
about each of these elements was not requested because it was not
available to all of the data suppliers. Companies received a point on
the scale for each practice included in their HWB initiative.
Accordingly, the Health & Well-Being Support Index (HWB support index) ranged from 0 to 7, with higher scores indicating a better
supported and more comprehensive initiative. Item-total correlations for the index components ranged from 0.49 to 0.76, and
Cronbach a ¼ 0.75. This level of internal consistency within the
HWB support index and subsequent indices meets the requirements
for preliminary research.27,28

Incentive Measurements
Three measures of incentive program structure were developed for the study, with each captured at both T1 and T2.
 Participation Requirements. This measure addressed the degree
to which earning an incentive was predicated on participating in
or completing an activity associated with the HWB initiative.
Four activities were included in this index: (a) biometric screening, (b) health assessment questionnaires, (c) participating in a
health intervention, and (d) completing a health intervention.
Each participation requirement a company included in the incentive program increased the participation requirement index by
one, yielding an index with a possible range of 0 to 4 at each of
the two periods of measurement. Cronbach a for the T1 index was
0.83, with item-total correlations ranging from 0.37 to 0.95; the
T2 Cronbach a was 0.79, with item-total correlations ranging
from 0.61 to 0.88.
 Targeted Health Requirements. This measure addressed the
degree to which earning an incentive was based on achieving
targets or making improvements in health-related outcomes. The

targeted outcomes included: BMI, weight, blood pressure, cholesterol, tobacco use, glucose, and ‘‘other’’ non-specified targeted improvements. Including any of the potential targeted
improvements as part of the incentive design increased the
Targeted Health Requirements index by one, yielding an index
with a possible range of 0 to 7 for each of the two measurement
periods. Cronbach a for the T1 index was 0.89, with item-total
correlations ranging from 0.70 to 0.88. The T2 Cronbach
a ¼ 0.86, with item-total correlations ranging from 0.27 to 0.96.
 Incentive Available. This measure was the total dollar amount of
the incentive.

Organizational Participation
Three measures that described employee participation in the
HWB initiative were developed for the study. Each was measured at
both T1 and T2; two were single-item indicators.
The participation index was based on the proportion of
employees who participated in four aspects of the HWB initiative:
biometric screening, health assessment, any degree of participation
in the incentive program, and participation in the incentive program
sufficient to earn at least a portion of the incentive. This index was
calculated by averaging the four proportions. Cronbach a for the T1
index was 0.95, with item-total correlations ranging from 0.82 to
0.96. The T2 Cronbach a was 0.91, with item-total correlations
ranging from 0.75 to 0.95.
A single item indicator of participation was the proportion of
employees who engaged in a health intervention. The second singleitem indicator was the dollar amount of the incentive earned.

Risk-Related Outcomes
The final set of measures included four composite indices,
each of which addressed different health outcomes in the employee
population and were universally available across the data suppliers
contributing data to the study. Outcomes measured included: cholesterol, as measured by LDL levels; blood pressure, as measured by
systolic and diastolic blood pressure levels; body mass and obesity,
as measured by BMI; and fasting glucose levels. Each of these
measures was captured for both T1 and T2.
Two classes of measures were calculated for each outcome.
The first class was the organizational-level mean score. The second
class of measures was the proportion of the employee population
that fell into each of several ordinally-ranked categories ranging
from commonly accepted biometric targets to high or extremely
high risk, with the sum of the proportions across the categories
equaling 1.00. For both classes of measures, data suppliers were
asked to exclude individuals with out-of-range biometric values
from their calculations.(Out of range values were defined as: BMI
less than 15 or greater than 70; systolic blood pressure less than 70
or greater than 220; diastolic blood pressure less than 40 or greater
than 130; glucose less than 45 mg/dL or greater than 500 mg/dL;
LDL less than 30 mg/dL or greater than 350 mg/dL)
To improve the sensitivity of the outcome measures used in
the analysis, weighted composite scales were created. Each outcome
reflected the degree to which the employee population deviated
from accepted biometric targets, with higher scores indicating a
greater degree of risk.
The first step in creating outcome indices was to avoid
unintentionally weighting the arithmetic averages to a greater
degree than all the other measures within each outcome area.
The categorical proportion measures were necessarily bounded
by 0 to 1, and further constrained to sum across the categories to
1. In contrast, the arithmetic averages were all substantially larger,
varying from the relatively small averages associated with BMI to
the larger values associated with systolic blood pressure or LDL
measurements. To avoid unintentionally allowing the average-based
measures from dominating a resulting scale score, the raw averages

were transformed to a scale of 0 to 1 by using the observed minimum
and maximum values across the two time periods for each measure.
The second step in creating the indices was to combine the
several proportions for each outcome measure into a composite
scale that reflected the goal of measuring deviation from the desired
biometric target, that is, increased risk. This was accomplished by
selecting weighting functions vi for each of the component measures, with larger values of vi assigned to the categories that
deviated more substantially from desired biometric readings. The
weights were chosen based on professional judgment. For each
outcome, Svi ¼ 1.0.
LDL cholesterol risk (LDL risk) specified as its targeted
outcome category the proportion of the study-eligible employee
population that achieved LDL levels less than 100 mg/dL. As the
low-risk category, this proportion was weighted at 0.00 for index
creation. The moderate category for LDL measurements specified
the proportion of employees with LDL readings in the 100 to
129 mg/dL range; this proportion was weighted at 0.15 for index
creation. The high category for LDL measurements specified the
proportion of employees with LDL readings in the 130 to 159 mg/dL
range; this proportion was weighted at 0.20 for index creation. The
very high category for LDL measurements specified the proportion
of employees with LDL readings 160 mg/dL and above; this proportion was weighted at 0.25 for index creation. Finally, the
company average LDL reading was transformed to a 0 to 1 range
and weighted at 0.40 in creating the composite index. The different
LDL risk indicators were all multiplied by their respective weights,
summed, and multiplied by 100 to create the final LDL risk index
for each of the two measurement periods.
Body mass index risk (BMI risk) specified as the target
category the proportion of employees with BMI readings in the
18.5 to 24.9 category (v0 ¼ 0.00). The moderate category for BMI
measurements specified the proportion of employees with BMI in
the 25 to 29.9 range (v1 ¼ 0.20). The high category for BMI was
specified as the proportion of employees with BMI 30 or higher
(v2 ¼ 0.40). The company average BMI reading was transformed to
a 0 to 1 range with v3 ¼ 0.40 in creating the composite index. The
four different BMI measures were all multiplied by their respective
weights, summed, and multiplied by 100 to create the final BMI risk
index for each of the two measurement periods.
For the glucose risk index the three proportional categorical
readings included the target (less than 100 mg/dL; v0 ¼ 0.00),
moderate (100 to 125 mg/dL; v1 ¼ 0.20), and high categories
(126þ mg/dL; v2 ¼ 0.40). The company average glucose reading
was transformed to a 0 to 1 range with v3 ¼ 0.40 for creating the
composite index. The four different glucose measures were all
multiplied by their respective weights, summed, and multiplied
by 100 to create the final glucose risk index for each of the two
measurement periods.
The blood pressure risk index included six measures, four of
which represented proportions of the employee population that fell
into biometric categorical outcome classes and two arithmetic
averages. The target category with v0 ¼ 0.00 was the proportion
of the employee population with systolic blood pressure reading less
than 120 combined with a diastolic reading less than 80. The
moderate category with v1 ¼ 0.15 was the proportion of the
employee population with systolic blood pressure in the 120 to
139 range or diastolic blood pressure in the 80 to 89 range. Systolic
blood pressure in the 140 to 159 range or diastolic blood pressure in
the 90 to 99 range fell into the high category with v2 ¼ 0.20. The
very high category with v3 ¼ 0.25 included the proportion of
employees with systolic blood pressure of 160 or higher or diastolic
blood pressure of 100 or more. If any individual employee did not
neatly fall into one of the categories with systolic reading in one
category and diastolic pressure in a different category, that individual was counted in the higher risk category, for example, blood

TABLE 1. Measures Used in the Study
Conceptual Area
Background characteristics

Organizational support
Incentives design

Organizational participation

Risk-related outcomes

Measure

Observed Range

Average

Std. Dev.

Service industry
Manufacturing industry
Proportion male
Average age
Proportion study eligible
Elapsed time covered by data
HWB support index
T1 participation requirements
T2 participation requirements
T1 targeted health requirements
T2 targeted health requirements
T1 incentive available ($)
T2 incentive available ($)
T1 participation index
T2 participation index
T1 health intervention
T2 health intervention
T1 incentive earned ($)
T2 incentive earned ($)
T1 LDL risk index
T2 LDL risk index
T1 blood pressure risk index
T2 blood pressure risk index
T1 BMI risk index
T2 BMI risk index
T1 glucose risk index
T2 glucose risk index

0–1
0–1
0–0.95
32.9–53.3
0.07–1
1–7
0–7
0–4
0–4
0–7
0–7
$50–$5,200
$0–$6366.62
0.09–1.00
0.00–0.98
0.00–0.99
0.00–0.96
$0–$7,474
$0–$9,784
6.00–53.36
15.02–56.67
0.43–54.68
5.55–45.70
8.00–66.56
15.40–69.52
0.00–60.00
10.17–42.13

0.391
0.374
0.561
44.769
0.449
2.983
4.253
1.569
1.483
3.069
4.839
$857.56
$988.50
0.728
0.703
0.120
0.104
$885.66
$872.04
31.341
29.149
26.152
24.291
41.591
43.687
25.567
23.844

0.489
0.485
0.256
3.328
0.180
1.526
2.127
1.507
1.409
2.525
2.081
$751.82
$879.06
0.193
0.184
0.258
0.242
$1083.57
$1074.04
7.888
6.030
6.754
5.998
8.923
8.952
7.904
6.627

pressure of 145/85 was in the high category rather than the moderate
category. Finally, the 0 to 1 transformed average systolic blood
pressure (v4 ¼ 0.20) and diastolic blood pressure (v5 ¼ 0.20) readings were also used in creating the blood pressure risk index. These
six blood pressure measures were all multiplied by their respective
weights, summed, and multiplied by 100 to create the final blood
pressure risk index for each of the two measurement periods.

Analysis
The data analysis plan had three distinct steps. In the first
step, the sample-wide characteristics for all the measures included
in the study were reviewed to provide a baseline context for the
subsequent analyses.
In the second step, the question of how companies evolved
their incentive plans over time was addressed by using a two-stage
cluster analysis model. In the first stage, Ward’s hierarchical
clustering model29,30 was applied to the incentive design measures
to answer the question of how many clusters—or types—effectively
described the ways in which companies evolved their incentive plan
designs over time. Because hierarchical clustering methods are
known to be susceptible to creating elongated chains when joining
objects, the second stage of clustering used the number of clusters
determined in the first stage and applied iterative centroid k-means
clustering methods31 to finalize the assignment of companies to the
appropriate incentive plan type.
The third step of the analysis considered the association
between the type and evolution of incentive plan and participation
in the HWB initiative, earning of incentives, and health outcomes.
This was addressed by estimating the average scores within each of
the incentive types on the different measures and comparing those
averages across the different groups. The over-time effectiveness of
the plans was determined from the estimated marginal means derived
from type-specific causal models(a total of 16 different causal models
were estimated. The detailed results of these models are available

upon request. This manuscript focuses on the outcomes of those
analyses) where the focus was on the within-group over-time differences in the predicted scores from those models, effectively controlling for the type of plan that was implemented and other
characteristics that may have influenced the measured biometric
outcomes. Data analyses were executed using SAS 9.4 (SAS Institute,
Inc., Cary, NC) and Stata 16.1 (StatCorp, LLC, College Station, TX).

RESULTS
Table 1 presents the averages, standard deviations, and
observed ranges for all of the company-level measures included
in the study. On average, companies demonstrated substantial
organizational support for their HWB initiative and associated
incentive plans. They were generally mid-range in their participation requirements, with a slight drop over time. Targeted health
requirements were also mid-range at T1 and increased substantially
by T2. The average amount of the incentive that was available
increased from $858 at T1 to $989 at T2. The amount of the available
incentive was highly skewed, with a T1 median of $600 and a T2
median of $676.
T1 participation in health assessment and the incentive program was quite robust with a slight, non-significant decrease over
time. Participation in health interventions was minimal at T1, and it
too declined over time. The amount of the earned incentive stayed
relatively consistent over time, with average earned incentives
approaching $900.( For some organizational-level data the reported
incentive earned exceeded the total incentive that was supposedly
available. The data were accepted as provided by the data suppliers)
The data for the amount of the incentive that was earned were also
highly skewed, with a T1 median of $529 and a T2 median of $530.
Three of the four risk index outcome measures (LDL, blood
pressure, and fasting glucose) indicated slight decreased risk over
time. The exception was BMI risk, where risk increased by more
than two points on the index.

TABLE 2. Key Incentive Design Types
Total
Sample
Sample size
174
Percentage
100%
Average scores on incentive design dimensions
1.569
T1 participation requirements (0–4)
1.483
T2 participation requirements (0–4)
3.069
T1 targeted health requirements (0–7)
4.839
T2 targeted health requirements (0–7)

Participationto-Outcomes

Combination

OutcomesFocused

ParticipationFocused

42
24%

29
17%

76
44%

27
16%

2.905
2.667
0.048
6.000

2.724
2.586
5.828
5.828

0.066
0.105
4.553
5.474

2.481
2.333
0.630
0.185

Explained
Variation

0.784
0.751
0.845
0.934

Participation requirements measure the degree to which earning an incentive was predicated on participating in or completing an activity associated with the HWB initiative.
Targeted health requirements measure the degree to which earning an incentive was based on achieving targets or making improvements in health-related outcomes.

Cluster Analysis
The cluster analysis of these data used the four measures of
requirements—T1 and T2 measures for both participation and
targeted health requirements—as the basis for deriving the typology
of incentive plans. These measures were selected because they
defined the context of expectations placed upon employees to earn
the available incentive.
These four requirements measures were all standardized to
x̄ ¼ 50 and s ¼ 10 so that no measure would disproportionately
influence the results due to having greater variability. The results
from the Ward’s hierarchical clustering indicated a peak in the cubic
clustering criterion at either four or five clusters. Both the pseudo F
statistic and the pseudo t-squared statistic indicated four clusters.
Based on this evidence, we specified the number of clusters/types as
equal to four and applied the convergent k-means algorithm for final
cluster assignment, estimating the four cluster centroids as determined from the Ward’s analysis. K-means quickly converged
yielding the four-cluster solution presented in Table 2, which
describes how the types differed in the incentive plan requirements
placed upon employees. For comparative purposes, the total sample
averages for these measures are also presented.
The first incentive design group was labeled Participation-toOutcomes. It included 42 companies, or 24% of the total sample. At
both T1 and T2 this incentive design type was characterized by strong
participation requirements. Initially, this group did not impose
targeted health requirements. By T2, however, this type had added
the most targeted health requirements on average of any of the four
types of incentive plans.
The second type, Combination, included 29 companies or
17% of the sample. These companies were characterized by ‘‘staying-the-course’’ throughout the study period, with substantial
requirements for both participation and achieving targeted health
outcomes at both T1 and T2.
Outcomes-Focused companies (n ¼ 76; 44%) were also consistent with their requirements over time. Participation was not
mandated or incented; earning incentives was based on achieving
targeted health-related outcomes and the requirements became more
stringent over time.
The final type of incentive plan represented companies that
were Participation-Focused (n ¼ 27; 16%). This group had reasonably strong and stable requirements for participation in health
assessment and intervention activities, but few requirements for
achieving targeted health outcomes.

Cluster Impact
Table 3 presents the mean scores by type for all the remaining
study variables. For most background organizational characteristics,
there were no statistically significant differences among the

different incentive design types. The average age of employees
in the different companies approached the traditional criterion for
statistical significance. This was largely due to the slightly younger
employee distribution in the Outcomes-Focused type. The elapsed
time covered for the data collection period varied substantially
across the types. Participation-Focused companies represented the
shortest implemented incentive period (x̄ ¼ 1.9 years), while Outcomes-Focused companies had the longest timeframe for incentive
plan implementation (x̄ ¼ 3.6 years).
The HWB support index varied significantly among incentive
types. Combination companies had the highest scores on the HWB
support index (x̄ ¼ 5.4), while Outcomes-Focused companies had
the lowest average scores on this index ( ¼ 3.5). The incentive
available at T1 and T2 also varied significantly by type. Outcomes-Focused companies offered by far the highest incentive
amounts, followed by Combination companies. Participation-toOutcomes and Participation-Focused companies offered incentives
of approximately equal value.
Outcomes-Focused companies had the highest scores on the
participation index, reflecting participation in the incentive program, but they had the lowest scores on participation in health
interventions. Reflecting the high incentive made available to
employees, the average earned incentive for this group was also
the highest.
Companies in the Combination type had the second highest
score on the participation index, and it increased slightly over time.
Participation in health interventions was relatively high at T1
compared with the other types but decreased over time. The average
incentive earned was the third-most of any of the types, and it
increased slightly over time.
Participation-to-Outcomes companies nearly matched Combination companies on the participation index but showed a slight
decrease over time. Participation in health interventions was the
highest for this group at T1, and it remained stable over time. The
average incentive earned by this group was the second highest of
any of the different types.
Companies in the Participation-Focused type had the lowest
scores on the participation index. Participation in health interventions exceeded only the lowest scoring Outcomes-Focused group,
while the amount of the incentive earned was the lowest of any
group at T1 but increased over time.
None of the between-group differences on the four outcome
measures were statistically significant. For three of the four measures, all groups registered an over-time decrease in risks. The BMI
risk index increased somewhat for each of the groups.
Table 4 presents the estimated marginal means for the four
outcome measures at T1 and T2, controlling for all other measures in
the multiple group structural equation models that were estimated.

TABLE 3. Company Characteristics by Incentive Design Type

Characteristic Averages
Service industry
Manufacturing industry
Proportion male
Average age
Proportion study eligible
Elapsed time covered by data
HWB support index
T1 incentive available ($)
T2 incentive available ($)
T1 participation index
T2 participation index
T1 health intervention
T2 health intervention
T1 incentive earned ($)
T2 incentive earned ($)
T1 LDL risk index
T2 LDL risk index
T1 blood pressure risk index
T2 blood pressure risk index
T1 BMI risk index
T2 BMI risk index
T1 glucose risk index
T2 glucose risk index

Participationto-Outcomes
0.357
0.381
0.563
45.092
0.419
2.833
4.643
$420.54
$538.05
0.670
0.624
0.249
0.252
$413.33
$436.28
29.913
28.088
24.428
22.663
41.441
42.292
26.810
23.748

Combination

OutcomesFocused

ParticipationFocused

Significance of
Differences
Across Types

0.379
0.483
0.572
45.123
0.497
2.690
5.379
$696.07
$753.31
0.672
0.707
0.238
0.155
$443.85
$514.16
34.095
29.735
27.689
25.532
43.106
44.331
24.770
23.095

0.434
0.342
0.551
44.051
0.446
3.579
3.513
$1,341.92
$1,526.01
0.818
0.772
0.003
0.003
$1,629.09
$1,434.57
31.347
29.523
26.086
24.272
41.241
44.538
25.162
24.164

0.333
0.333
0.572
45.903
0.453
1.852
4.519
$457.04
$448.63
0.627
0.630
0.116
0.095
$430.37
$444.22
30.589
29.115
27.370
25.542
41.182
42.771
25.631
23.897

NS
NS
NS
0.059
NS
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
< 0.001
<0.001
<0.001
NS
NS
NS
NS
NS
NS
NS
NS


Data reported represent the simple within-group mean scores on all measures without controlling for any other measures in the models. Specific tests of significance between
each type were not conducted to avoid making more comparisons than justified given the degrees of freedom associated with the independent variable.

For all four groups, LDL risk decreased significantly, with the
greatest decrease in the Combination group.
Three of the four groups registered statistically significant
decreases in blood pressure risk, with the largest decrease again
found in companies using the Combination type of incentive plan.
Participation-Focused companies registered a slight, non-significant
decrease in blood pressure risk.
None of the different types of incentives plans showed
decreases for the BMI risk index. For three of the four groups,

the increase in BMI risk was not statistically significant. However,
the increase in BMI risk was statistically significant for the Outcomes-Focused group.
For glucose risk, the Participation-to-Outcomes group and
the Combination group showed significant decreases in risk, with a
greater reduction seen in the Participation-to-Outcomes type. The
Participation-Focus group achieved risk reduction that bordered on
statistical significance, while the Outcomes-Focused group
achieved a small, non-significant reduction in glucose risk.

TABLE 4. Estimated Marginal Means for Outcome Measures
Outcome Measure
LDL risk index

Blood pressure risk index

BMI risk index

Glucose risk index

Statistic

Participation-to-Outcomes

Combination

Outcomes-Focused

Participation-Focused

T1 marginal mean
T2 marginal mean
Over-time t-test
Probability
T1 marginal mean
T2 marginal mean
Over-time t test
Probability
T1 marginal mean
T2 marginal mean
Over-time t test
Probability
T1 marginal mean
T2 marginal mean
Over-time t test
Probability

30.030
28.060
5.482
0.000
24.250
22.427
5.199
0.000
41.225
42.437
0.999
NS
26.305
24.042
2.715
0.010

33.933
29.612
7.359
0.000
27.934
25.273
5.028
0.000
43.233
44.153
0.753
NS
24.540
23.193
2.301
0.029

32.019
28.666
8.170
0.000
26.314
24.219
4.322
0.000
42.174
44.521
2.661
0.010
24.705
24.154
0.881
NS

30.561
29.304
2.767
0.010
26.678
25.505
1.239
NS
41.653
42.449
0.524
NS
25.680
23.893
1.854
0.075


Estimated marginal means were derived from the predicted scores from structural equation models predicting outcomes. As such other significant predictors in the model (eg,
industry, the amount of the available incentive, etc) were statistically controlled and adjusted in these estimates.

DISCUSSION
This study found that incentive designs associated with
employer HWB initiatives generally fell into one of four distinct
types, with three types remaining relatively stable and the fourth
type evolving substantially over the study period. The three stable
types were incentive designs focused on participation, outcomes,
and a combination of participation and outcomes, respectively. The
fourth type of incentive design evolved over time toward a slightly
reduced focus on participation and a substantially increased focus
on outcomes. The three stable types accounted for about threequarters of all companies in the study, with the Outcomes-Focused
type representing the largest single category at 44% of all companies in the sample. While organizations in the stable incentive types
maintained the same general approach throughout the study period,
companies made modest changes in the overall incentive amount,
dollar values associated with each incentive requirement, and the
number of requirements associated with an incentive. The general
pattern was to increase the size of the incentive and to require
participants to do more to earn it.
The type of incentive strategy companies used had a substantial
influence on the size of the incentive offered and the amount of HWB
support provided to employees. Companies focusing their incentives
on achieving health outcomes offered substantially larger incentives
than any of the other three incentive types. At Time 1, for example, the
$1342 average incentive offered by the Outcomes-Focused group was
nearly double the next highest incentive type (Combination, $696)
and about three times the amount offered in the other two groups.
Conversely, the Outcomes-Focused companies scored more than a
full point lower than companies in any of the other incentive types on
the HWB support index (3.5 out of 7 possible points vs 4.5 to 5.4).
This pattern suggests the Outcomes-Focused companies relied primarily on the incentive per se to drive improvements in health
outcomes, rather than viewing the incentive as a tool within the
context of a supportive HWB initiative and organizational culture.
The primary reliance of the Outcomes-Focused companies on
incentives did not necessarily translate into higher levels of health
risk change. On three of the four outcome measures—cholesterol,
blood pressure, and blood glucose—statistically significant reductions in risk were seen for the companies with Participation-toOutcomes and Combination incentive plan designs. The OutcomesFocused group achieved decreases in risk for only cholesterol and
blood pressure. However, the BMI risk index score increased about
twice as much in Outcomes-Focused companies compared with the
other three groups. Overall, despite offering much greater financial
incentives for health improvement than other groups, the OutcomesFocused companies achieved less overall improvement across the
four health outcome measures.
While nearly 40% of study companies started the study
period with a greater focus on participation requirements, approximately 84% ended the study period with a greater focus on targeted
health requirements. Such shifts toward rewarding outcomes may
have been influenced by the Patient Protection and Affordable Care
Act (ACA) of 2010,32 since all but four of the study companies had
baseline (T1) data in 2010 or later. The ACA enacted into statute and
broadened 2006 HIPAA regulations governing the use of health plan
incentives as part of company-sponsored wellness programs. This
statutory protection and widespread media coverage of early adopters of Outcomes-Focused approaches may have encouraged this
shift among companies toward offering incentives linked to health
improvements. Baseline study years for companies ranged from
2008 through 2015 (70% began in 2012 to 2014) with follow-up (T2)
study years ranging from 2014 through 2017 (98% ended in 2015
and 2016).
Since the enactment of ACA, the research literature on
employer considerations for incentive designs has focused on other

sources of influence. Jenkins et al33 suggest that companies use
employee feedback to inform development of incentive designs,
while Barleen et al24 suggest employer decisions may be influenced
by guidance from third-party benefit consultants or HWB vendor
partners. Such factors influencing employer decisions about incentive design in the post-ACA era is an area ripe for future research.
The current study may be among the first to examine the use
of HWB support practices in association with incentive design
differences. It is unclear why companies using an OutcomesFocused approach provided fewer HWB support strategies to help
employees achieve those outcomes. Perhaps Outcomes-Focused
companies had cultures encouraging high levels of employee
accountability for job-related outcomes and this incentive design
was merely an extension of that core value. A detailed review of
HWB supports implemented by Outcomes-Focused companies
reveals they had the lowest scores for HWB strategic planning
effectiveness, organizational support effectiveness, participation
strategies (e.g., communications) effectiveness, and follow-up
and referral for elevated biometric screening values, all of which
contributed to the lowest HWB support index score (3.5). These
lower scores across multiple core HWB support dimensions also
suggests that these organizations may have had less mature HWB
strategies or were less aware of the kinds of supports essential to
achieve healthy population change.
Similar to other research, the current study observed population-level improvements in cholesterol, blood pressure and glucose,
but BMI trended upward. This may be attributed to the relative
complexity of lifestyle behavior changes involved in losing weight.
Population-level changes in BMI are difficult without substantial
intervention, and participation in health interventions was low
among study companies. Additionally, blood pressure, LDL, and
glucose levels are more readily influenced by pharmaceutical
interventions, and it is likely that elevated biometric screening
results resulted in referrals to clinical care. Indeed, analysis of
the component items of the HWB support index indicates that more
than half of the companies in the current study implemented followup and referrals for employees with elevated health risk measures.
However, many physicians may be unlikely to have the resources,
skills, or time to successfully manage overweight/obesity in their
practice in accordance with US Preventive Services Task Force
recommendations.34–36
As a whole, the current study findings suggest that incentives
designs vary in their influence on participation and health outcomes.
Participation-Focused incentive designs were associated with lower
participation index scores and with improvements in only one of the
four health outcomes (LDL). The Outcomes-Focused incentive
design was associated with higher participation scores for health
assessment but not for health interventions, and with improvement
in blood pressure and LDL risk. However, both incentive designs
using a combination of participation and health outcomes linkages
were associated with higher health intervention participation rates
and improvements in LDL, blood pressure, and fasting glucose
outcomes. The use of combination approaches to improve individual-level health outcomes is supported by at least one other study,
which found changing an incentive structure from one focused only
on participation to one that linked a portion of the incentive to
participation and a portion to achievement of biometric targets
resulted in individual-level improvements in hemoglobin HA1c
and weight management outcomes.18 However, this finding was
not supported in a study by Barleen et al,24 which compared the
influence of four incentive designs (participation-based, hybrid,
outcome-based, and no incentive) on health behavior program
participation and achievement of several health improvement targets, including BMI, blood pressure, and non-high density lipoprotein cholesterol. That study found no between-group differences in
program participation or the achievement of health improvement

targets after controlling for potential confounders, such as employee
demographics, communications, culture, and incentive amounts/
characteristics. At least some of the variation in findings between
these studies may be attributable to uncontrolled confounding
variables, despite attempts to control the influence of HWB support,
program communication quality, and other possible confounders.
None of the incentive designs in this study were associated
with improvements in BMI. While some research links the use of
incentives with individual-level increases in physical activity, this
often does not translate into weight loss at the population
level.11,13,37 It is likely that behavioral strategies beyond incentives
must be employed to sustain behavior change over time for a
sufficient portion of a population to achieve population-level
health outcomes.
Despite some interesting differences in effectiveness emerging among the four incentive design groups, the current study
reinforces past research demonstrating the need for substantial
HWB support beyond incentives to produce population-level health
outcomes. Accordingly, we encourage future research to focus on
better understanding the role of incentives within the context of a
broader HWB initiative. Many researchers familiar with incentives
and health behavior change research exhort employers to invest in
the use of evidence-based interventions that support sustainable
behavior change and to embed those interventions into a comprehensive HWB strategy that includes a population-based approach,
strategic planning with measurable objectives, leadership support,
organizational commitment, comprehensive communications, and a
workplace environment that supports such change.23,38-40

Study Limitations and Future Research
Several limitations of the current study call for caution in
applying the findings to decisions about how to design effective
incentive strategies. Many records provided by data suppliers did
not include information about the total number of employees
represented by a given client. This is because some data suppliers
were engaged by clients to administer incentives plans for only the
subset of the employee population enrolled in a particular health
plan. As such, the results might be subject to a selection effect
manifesting as sampling bias, with systematic error due to a nonrandom sample of a population.41 Therefore, these findings may not
be generalizable to all companies. In particular, the distribution of
incentive strategies (eg, Outcomes-Focused strategies representing
44% of organizations) and changes to those strategies may be
influenced by the fact that data for this study was supplied by
organizations that manage incentives as part of their HWB services.
Similarly, selection bias may be at play in some of the
longitudinal findings. Companies in this study were required to
have data available during two timeframes. That requirement may
have selected organizations that had been successful in achieving
their employee HWB goals related to participation and/or risk
outcomes. Companies that were unsuccessful or that lacked consistent leadership support may have been less likely to maintain such a
contract and would have, therefore, been excluded from this study.
This raises another possible limitation: there is no control group in
this study, that is, companies that offered no incentives at all or that
had no HWB initiatives.
The length of time between T1 and T2 measures emerged as a
significant predictor in study models and differed across the various
incentive groups. For example, Outcomes-Focused companies represented the longest length of time between measurement periods
(mean of 3.6 years) while Participation-Focused companies represented the shortest length of time (mean of 1.9 years). Such differences complicate the interpretation of study findings. While we
considered limiting the study to a specific length of time, we chose
not to do so to maintain a sufficient sample size and to explore the
role of elapsed time on study outcomes. Study companies had

varying durations between measures and this may have been related
to the observed changes in BMI. In the US adult population, obesity
increased from 34.9% to 42.4% between 2011 to 2012 and 2017 to
2018.42 Within the context of the current study, a 7-year duration
between biometric measures with a 4-percentage point increase in
obesity might be interpreted as a success, while the same outcome
over a 2-year period could be judged as ineffective. Given the
importance of study duration, this should be accounted for in future
studies of this nature.
Another limitation of the current study was the small sample
size within each of the incentive plan design types. While the
differences observed between the groups were statistically significant, the small samples necessarily limit confidence in the stability
of these estimates.
The use of the HWB support index was a unique feature of
the current study and some interesting differences were identified
across the incentive types. However, the use of such measures could
be improved upon in future research. For this study, elements of the
HWB support index were based on information data suppliers had
about each of their clients. Given their role in implementing HWB
initiatives for their clients, some of the elements (eg, use of referrals
and follow-up for out-of-range biometric values) were readily
known by the data supplier. Other elements (eg, ratings of organizational support for HWB) were more subjective and may have
been more accurately measured by asking the company/client to
provide this information. Data suppliers were not asked to request
information from clients to reduce the burden associated with
data collection, but future research might opt to gather such
information from the employer using a validated measurement
tool such as the HERO Health and Well-being Best Practices
Scorecard in Collaboration with Mercer(c) (HERO Scorecard)40
to assess HWB support.
The definition of participation in health interventions in this
study was quite broad. Participation was defined as ‘‘active participation in at least one interactive component of a health behavior
change intervention in the study year.’’ A component was ‘‘interactive’’ if a bi-directional communication occurred between an HWB
professional or expert system and an eligible individual as part of
health education, health coaching, or technology-supported intervention. Participation in health interventions was very low in the
current study sample and little information was available on the
nature of behavior change interventions provided by study companies. Future research should consider more robust measures and
inclusion criteria in exploring the influence of incentive design on
intervention participation.
Given these limitations, the current study findings should be
interpreted with caution and considered exploratory. Even so, the
study forges new ground by including measures that have not been
examined previously. Measures of change in incentive designs over
time, use of HWB support practices, time between measurement
periods, and population-level health outcomes are not well represented in published research studies and merit further examination.
As such, this study provides several promising new directions for
future research on incentives as well as broader HWB issues.

CONCLUSION
The current study identified four general types of incentives
designs used in real-world settings, which distinguishes it from
more narrowly controlled studies of a single incentive design. It also
examined population-level rather than individual-level health outcomes, which may be more meaningful for companies investing in
HWB initiatives. Incentive designs varied in their influence on
population-level participation and health outcomes, with no one
design being clearly superior to others. This suggests the need for
more research on the influence of different incentive designs on
outcomes of interest to employers.
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